Private Equity

Bringer Air Cargo's new direct route to Navegantes isn't just a flight path; it's a strategic move reshaping supply chains for Brazil's economic engine.

SEG Solar's $80M Indonesian plant isn't just a new factory; it's a strategic move to build a non-FEOC solar supply chain for the United States.

This new partnership is more than a sponsorship. It's a strategic move to close the gender data gap in sports science and redefine athlete care for women.

AMTD Digital's subsidiary is on a global hotel buying binge, but a history of extreme stock volatility and underlying financial risks raise serious questions.

After a NYSE delisting, FOXO Technologies is betting big on healthcare acquisitions. Is this a savvy turnaround or a high-risk gamble for investors?

As Spruce Biosciences preps its rare disease drug for FDA review, the addition of a commercial veteran signals a high-stakes shift from R&D to market.

A fintech firm's new hire seems distant, but it signals a crucial shift in how capital flows into life-saving research and healthcare innovation.

Quipt Home Medical's acquisition by private equity offers a massive premium to shareholders and sets the stage for aggressive M&A in the home respiratory care market.

Talen Energy unveils a major executive overhaul and a novel compensation plan, signaling a strategic pivot to dominate the energy-hungry AI data center market.

A landmark green ammonia project in Spain offers a blueprint for industrial decarbonization, holding key strategic lessons for the biopharmaceutical sector.

The infrastructure giant's new €800M share repurchase isn't just for shareholder value; it's a strategic move to fund future growth and acquisitions.

Beyond a simple date change for its $10M dividend, Dominari Holdings is signaling a major strategic shift, funded by investment gains and aimed at AI.

AIP Realty Trust's $78.7M acquisition of AllTrades pivots on a complex related-party deal and reverse takeover, putting unitholder trust to the test.

Clairvest's successful exit from F12.net yields a 35% IRR, showcasing a powerful growth strategy for private equity in Canada's booming MSP market.

BlackRock's latest fund distributions reveal a heavy reliance on 'return of capital,' especially in its resource funds. What does this mean for investors?

Two Bay Area event firms gain a key certification, strategically positioning them to tap into the lucrative healthcare conference market via supplier diversity.

A key 2026 legal forum reveals the DOJ's expanding False Claims Act focus, putting cybersecurity non-compliance and private equity investors on notice.

From biopharma to webcomics, shareholder lawsuits reveal the perils of misleading investors. A look at four companies facing legal and financial fallout.

A major port expansion promises economic revival for the Baie Verte Peninsula, but at what cost to the environmental and community health of the region?

Updated trial results for Lilly's Inluriyo-Verzenio combo extend life without chemo, positioning the firm for dominance in a competitive oncology market.